Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is VALSARTAN DISODIUM, with a corresponding US DMF Number 33648.
Remarkably, this DMF maintains an Active status since its submission on March 07, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 03, 2019, and payment made on March 07, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II